Literature DB >> 8014475

Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.

E Spiess1, A Brüning, S Gack, B Ulbricht, H Spring, G Trefz, W Ebert.   

Abstract

We investigated the appearance and activity of the cysteine proteinase cathepsin B and its physiological inhibitors, stefins A and B, at the cellular level in human tumor cell lines HS-24, derived from a primary lung tumor (squamous cell), and SB-3, derived from a metastasis (lung adenocarcinoma). In addition to cathepsin B, these tumor cells also expressed the immunologically and functionally related cathepsin L, but not cathepsin H. Stefin A was found in HS-24 but not in SB-3 cells; stefin B was found in both cell types. Using a specific fluorogenic cytochemical assay, the intracellular activity of the enzyme was localized and quantified. Thus, the cellular cathepsin B kinetics for the synthetic substrates Z-Arg-Arg-4M beta NA and Z-Val-Lys-Lys-Arg-4M beta NA, its pH dependence and inhibition by E64, stefins A and B, and cystatin C could be determined. From these measurements it appeared that the enzyme exhibited different cleavage rates for these substrates in the different cell types, showed considerable cleavage activity at neutral pH, which was stable under these conditions for extended time periods, and was highly sensitive to the inhibitors E64 and cystatin C but was considerably less sensitive to stefins, particularly stefin A. By conventional light microscopy, confocal laser scanning microscopy, and electron microscopy the enzymatic activity was localized in lysosomes, as expected, but also in the endoplasmic reticulum, nuclear membrane, and plasma membrane. The endoplasmic reticulum is a site at which only pre-mature enzyme forms exist, which are usually not active. The appearance of enzymatic activity at the plasma membrane confirms earlier biochemical and immunofluorescence microscopic investigations. The different sites of localization within the cells make it likely that different forms of the enzyme are expressed simultaneously, which follow alternate ways of processing and sorting. Taken together, the results support an involvement of the enzyme under extracellular conditions in degradative processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014475     DOI: 10.1177/42.7.8014475

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  11 in total

1.  75-kd sirtuin 1 blocks tumor necrosis factor α-mediated apoptosis in human osteoarthritic chondrocytes.

Authors:  Hanna Oppenheimer; Odile Gabay; Hadar Meir; Amir Haze; Leonid Kandel; Meir Liebergall; Viktoria Gagarina; Eun Jin Lee; Mona Dvir-Ginzberg
Journal:  Arthritis Rheum       Date:  2012-03

Review 2.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

3.  Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

Authors:  H H Heidtmann; U Salge; M Abrahamson; M Bencina; L Kastelic; N Kopitar-Jerala; V Turk; T T Lah
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

4.  Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis.

Authors:  M Kasper; P Lackie; M Haase; D Schuh; M Müller
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

5.  Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B.

Authors:  C J Van Noorden; T G Jonges; J Van Marle; E R Bissell; P Griffini; M Jans; J Snel; R E Smith
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

6.  NF-kappaB protects from the lysosomal pathway of cell death.

Authors:  Ni Liu; Srikumar M Raja; Francesca Zazzeroni; Sunil S Metkar; Ramila Shah; Manling Zhang; Yue Wang; Dieter Brömme; William A Russin; Justine C Lee; Marcus E Peter; Christopher J Froelich; Guido Franzoso; Philip G Ashton-Rickardt
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

7.  Cathepsin B mediates cleavage of herpes simplex virus type 1 origin binding protein (OBP) to yield OBPC-1, and cleavage is dependent upon viral DNA replication.

Authors:  Malen A Link; Laurie A Silva; Priscilla A Schaffer
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

Review 8.  Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate.

Authors:  Stewart D Chipman; Fred B Oldham; Gabriella Pezzoni; Jack W Singer
Journal:  Int J Nanomedicine       Date:  2006

9.  The C-terminal subunit of artificially truncated human cathepsin B mediates its nuclear targeting and contributes to cell viability.

Authors:  Felix Bestvater; Claudia Dallner; Eberhard Spiess
Journal:  BMC Cell Biol       Date:  2005-04-04       Impact factor: 4.241

10.  The functional expression and characterisation of a cysteine peptidase from the invasive stage of the neuropathogenic schistosome Trichobilharzia regenti.

Authors:  Katerina Dolecková; Martin Kasný; Libor Mikes; Jared Cartwright; Petr Jedelský; Eric L Schneider; Jan Dvorák; Adrian P Mountford; Charles S Craik; Petr Horák
Journal:  Int J Parasitol       Date:  2008-07-26       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.